GENEVA, Aug. 21 -- WILLETT, W., Scott filed a patent application (US2026/015250) for “RECOMBINANT HUMAN PENTRAXIN-1/PENTRAXIN-2 (RHPTX-1/2) FUSION PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES AND OTHER PATHOLOGIES”. With publication no. WO/2026/174184, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/17
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....